Event Date/Time: Nov 21, 2013 / 8:00 am - (EST) End Date/Time: Nov 21, 2013 / 6:00 pm - (EST)
Registration Date: Nov 20, 2013 Time: 23:59:00 - (EST)
Early Registration Date: Oct 18, 2013 Time: 23:59:00 - (EST)
Report as Spam

Description

Presented by the New York Academy of Sciences, this conference will explore the bridge between science and regulation for the nascent field of nanomedicines.  Nanomedicines hold great promise for addressing some of the most challenging problems in nearly every medical specialty, and the field has the potential to generate many new opportunities for improving human health. However, there are also concerns that the fundamentally different properties of nanoparticles compared with bulk materials may pose significant safety and toxcity issues, and therefore require additional regulatory scrutiny.     This one day conference will focus on:
  • Current US and international regulatory frameworks for nanomedicines, and the future needs ahead;
  • Additional safety and toxicity research needed to determine unknown properties of nanomaterials; and
  • Lessons learned from featured drug development case studies of nanomedicines.

Keynote Speaker

Sally Tinkle, PhD, IDA/Science and Technology Policy Institute

Featured Speakers

Yechezkel (Chezy) Barenholz, PhD, Hebrew University of Jerusalem

Raj Bawa, MS, PhD, Bawa Biotech LLC and Rensselaer Polytechnic Institute

Neil Desai, PhD, Celgene Corporation

Rogério Gaspar, PhD, University of Lisbon

Scott E. McNeil, PhD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research

Stefan Mühlebach, PhD, Vifor Pharma Ltd. and University of Basel

Ritu Nalubola, PhD, FDA

Lawrence Tamarkin, PhD, Cytimmune

 

 

Venue

250 Greenwich Street, 40th Floor
New York
New York
United States
MORE INFO ON THIS VENUE

Conference Speakers

Keynote Speaker

Sally Tinkle, PhD, IDA/Science and Technology Policy Institute

Featured Speakers

Yechezkel (Chezy) Barenholz, PhD, Hebrew University of Jerusalem

Raj Bawa, MS, PhD, Bawa Biotech LLC and Rensselaer Polytechnic Institute

Neil Desai, PhD, Celgene Corporation

Rogério Gaspar, PhD, University of Lisbon

Scott E. McNeil, PhD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research

Stefan Mühlebach, PhD, Vifor Pharma Ltd. and University of Basel

Ritu Nalubola, PhD, FDA

Lawrence Tamarkin, PhD, Cytimmune

Additional Information

Location

The New York Academy of Sciences

250 Greenwich St. 40th Fl

New York, NY 10007